The cannabis compound known as CBD is being touted as a treatment for a variety of conditions. But the substance’s uncertain legal status is stalling serious investigation

Quick Read

Funding is harder to find in general, and the current approach favors low-risk research and proposals by older scientists and white men

Quick Read

For researchers who study the genetics of MDD, it’s become a numbers game: To reach statistical power, they need larger cohorts.

Quick Read

“If finalized, it would be the most substantial policy change in biomedical research policy in decades,” says Kathy Hudson, deputy director for science, outreach and policy at the US National Institutes of Health in Bethesda, Maryland.

Quick Read

Op-Ed by Carl Elliott: “If you want to see just how long an academic institution can tolerate a string of slow, festering research scandals, let me invite you to the University of Minnesota, where I teach medical ethics.”

Quick Read

Ethicists and health policy experts issue a call – and recommendations – for better regulation and guidance of crucial quality improvement health care research

Read More

Little is known about how pregnant women respond to most drugs. The Second Wave Initiative was launched to respond to this problem.

Read More